Stakeholders ask FDA to consolidate accelerated approval guidances, clarify trial assessments
Regulatory NewsFerdous Al-Faruque
GuidancePharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsFerdous Al-FaruqueGuidancePharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)